[問題] OG11-CR116

看板GMAT (GMAT入學考試)作者lovekyoko (Nothing is impossible扔)時間16年前 (2008/05/29 01:22)推噓0(0推 0噓 0→)

留言0則, 0人參與討論串1/2 (看更多)

116. The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary. Which of the following, if true, most strongly supports the pharmaceutical industry's argument against the challenge made above? 這題是不是要說明解釋為什麼製藥和其他行業的專利權不同在發展成本皆高的情況下那(D)An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug. 我看不懂這提的意思可以解釋一下嗎 (B)Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete. B的意思是說在新藥獲得專利之後能夠上市之前有10年的臨床實驗請問是因為臨床實驗需要10年所以使得他的收入晚了10 如果沒有延長專利會有仿冒的產品投入市場造成損失是這樣嗎?????? 但是其他行業勒都不怕有這樣的問題嗎天阿我越想越糊塗麻煩一下囉 orz -- 女:老闆.我要叫一桶瓦斯我:小姐.幾點了.還在叫瓦斯啊女:我要洗澡沒瓦斯啊.當然要叫瓦斯啊我:我要打泡還找不到女人咧女:我有再做.可以算你便宜一點喔.你要不要.我現在可以去你那邊我:.......................... 來吧 -- ※ 發信站: 批踢踢實業坊(ptt.cc) ◆ From: 203.73.98.104 ※ 編輯: lovekyoko 來自: 203.73.98.104 (05/29 01:33) ※ 編輯: lovekyoko 來自: 203.73.98.104 (05/29 01:43)